Introduction: Impatiens species have been traditionally used for the treatment of various diseases related to inflammation and cancer, and the aerial parts of these plants are considered particularly promising sources of bioactive compounds. The present investigation was designed to study chemical composition, cytotoxic activity, and nitric oxide inhibition properties of the essential oil and solvent extracts obtained from the aerial parts of Impatiens verrucifer. Methods: Essential oil of Impatiens verrucifer, obtained by hydrodistillation, was analyzed using gas chromatography-flame ionization detection/mass spectrometry (GC-FID/MS) analysis. Column chromatography combined with Nuclear Magnetic Resonance (NMR) analysis of the solvent extracts enabled the isolation and structure elucidation of purified compounds. Cytotoxicity and nitric oxide inhibitory activities were evaluated using standard assays. Molecular docking studies were performed to examine the interactions of the major constituents with target proteins. Results: A total of thirty-six compounds were identified in the tested oil, with sesquiterpene hydrocarbons and their oxygenated derivatives accounting for a significant proportion (57.22%). Among them, β-eudesmol (10.33%), elemol (10.11%), and (E)-nerolidol (8.96%) were identified as the predominant constituents. From solvent extracts, ten compounds (1-10) were isolated and structurally elucidated, eight of which (1-2, 4-5, and 7-10) were identified for the first time in the Impatiens genus. The essential oil exhibited notable cytotoxicity against four human cancer cell lines, including mouth epidermoid carcinoma (KB), hepatocellular carcinoma (HepG2), lung carcinoma (A549), and breast carcinoma (MCF-7), with the half-maximal inhibitory concentration (IC50 values) ranging from 28.36 ± 1.03 to 53.60 ± 3.39 μg/mL, while the solvent extracts showed the most potent nitric oxide inhibitory activity, with the lowest IC50 value of 27.60 ± 1.02 μg/mL. Discussion: The experimental findings were further supported by molecular docking simulations, which showed that β-eudesmol exhibited inhibitory activity comparable to that of the standard phosphatidylinositol 3-kinase (PI3K) inhibitor, idelalisib. Conclusion: This is the first report on the chemical composition and pharmacological activities of I. verrucifer. These results highlight the potential anticancer and anti-inflammatory properties of both the essential oil and solvent extracts of this species.